Home > Press > NineSigma Adds Key Program Management Team Members to Oversee Increasing Project Demand
Irina Shiyanovskaya, Stephanie Orellana, and Ryan Hartschuh Bring Ph.D. Level Expertise in Industries Including Advanced Materials, Biotechnology, Pharmaceuticals and Nanotechnology
NineSigma Adds Key Program Management Team Members to Oversee Increasing Project Demand
Cleveland, OH | Posted on December 4th, 2007
NineSigma, a leading provider of open innovation solutions, today announced the expansion of its program management team, including Irina Shiyanovskaya, Ph.D., Stephanie Orellana, Ph.D. and Ryan Hartschuh, Ph.D. As the result of an increase in demand and diversity of open innovation projects from Global 1000 companies, NineSigma added strategic program management resources to support the growing client demand.
Dr. Shiyanovskaya, a physicist and materials scientist, joins NineSigma as a Program Manager with industrial and academic expertise in fields including advanced materials, polymers/liquid crystals, bioengineering, nanotechnology, organic electronics and photonics. Prior to joining NineSigma, Dr. Shiyanovskaya was a Principal Scientist at Kent Displays Inc., where she developed flexible display technology. Dr. Shiyanovskaya, who serves as an Adjunct Professor at Case Western, earned an MS in Physics and Materials Science from Kiev National University and a Ph.D. in Physics and Mathematics from the Institute of Physics, National Academy of Sciences in Ukraine.
Dr. Orellana brings significant experience in education, biomedical research, project development, and management, and joins NineSigma as a Program Manager responsible for designing, consulting and executing client projects. Prior to joining NineSigma, Dr. Orellana served as faculty at the University of Washington and Case Western Reserve University, where she was responsible for the overall deployment and implementation of research projects specifically related to understanding the cellular mechanisms of human disease. Dr. Orellana received a BS in Biology from MIT and earned her Ph.D. in Physiology and Pharmacology from the University of California at San Diego.
Dr. Ryan Hartschuh, with expertise in optics, polymer science, and nanotechnology, joins NineSigma as an Assistant Program Manager. Prior to NineSigma, Dr. Hartschuh helped to develop a new spectroscopy technique capable of topographic and spectroscopic imaging with spatial resolution unprecedented for optical microscopy. Dr. Hartschuh received a BA in Physics from The College of Wooster and his Ph.D. in Polymer Science in 2007 from the University of Akron.
"A key component to NineSigma's unique open innovation approach is the talent pool of Ph.D. level program managers serving a diverse customer base," said Paul Stiros, CEO of NineSigma. "These strategic additions to our program management team further exemplify the growth we continue to see in open innovation projects from diverse industries and disciplines."
NineSigma partners with Global 1000 companies to transform their innovation capabilities by connecting them with the very best innovators from around the world. NineSigma's proprietary process for Open Innovation enables companies to dramatically improve speed to market while lowering product development costs. NineSigma's open network of innovators is the largest of its kind and spans industries, geographies, and technical disciplines. Companies such as P&G, GlaxoSmithKline, DuPont, Kraft, General Mills and Unilever engage NineSigma to build new innovation capabilities that leverage research and innovation globally to deliver greater value to their customers.
For more information, please click here
Copyright © Marketwire
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
New method allows for greater variation in band gap tunability: The method can change a material's electronic band gap by up to 200 percent January 31st, 2015
Evidence mounts for quantum criticality theory: Findings bolster theory that quantum fluctuations drive strange electronic phenomena January 30th, 2015
Everything You Need To Know About Nanopesticides January 30th, 2015
DNA nanoswitches reveal how life's molecules connect: An accessible new way to study molecular interactions could lower cost and time associated with discovering new drugs January 30th, 2015
Nexeon Board Changes Announced January 29th, 2015
Rice's Naomi Halas to direct Smalley Institute: Optics pioneer will lead Rice's multidisciplinary science institute January 15th, 2015
SUNY Board Appoints Dr. Alain Kaloyeros as Founding President of SUNY Polytechnic Institute January 13th, 2015
Blend Therapeutics Appoints Distinguished Physician Scientist, Dennis Ausiello, MD, to Board of Directors January 8th, 2015